Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |